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Bullous pemphigoid antigen 2 (BPAG2) is a 180 kDa 
type II trans1nembrane protein associated with 
hemidesmosomes (HDs) in basal keratinocytes. To 
better understand how BP AG2 promotes keratino-
cyte adhesion to epidermal basement membrane 
(BM), purjfied IgG against a baculovirus- encoded 
recombinant was used to localize its carboxyl termi-
nus in hu~an skin by ilnmunogold electron micros-
copy (IEM). A 2.1-kb BPAG2 eDNA encoding the 
distal extracellular domain and carboxyl terminus of 
BPAG2 was used in a baculovirus _expression system 
to create virus that produced a 70-kDa recombinant 
form of BPAG2 (BV4). BV4 was purified, character-
ized, and used to raise high-titer specific rabbit IgG. 
Purified anti-BV 4 IgG bound the epidermal side of 1 
M NaCl split skin and bound only BPAG2 on immu-
T h. e a-dhesion of epidermis to basement membrane is mediated through an atta chment complex composed of hemidesmosomes (HDs), anchoring filaments, lamina densa-associated proteins, and anchoring fibrils (Gipson et a/, 1987; Champliaud et al, 1996). 
T he ultrastructural subunits within this complex anchor the keratin 
.intermediate filament cytoskeleton of basal keratinocytes to unde r-
lying fibt;Uar components of the dermis (i.e., collagen fib ers, 
beaded microfilaments, and elastic nucrofibrils) . Acquired or inher-
ited abnormalities of constituent proteins within tlus attachment 
complex have been directly linked to diseases characterized by 
subepidermal blister formation (Stanley, 1992; Yancey, 1995; 
Borradori and Sonnenberg, 1996; Christiano and Uitto, 1996). One 
prote in within this attachment complex that is thought to play an 
important role in epidermal adhesion is bullous pemphigoid antigen 
2 (BPAGZ). 
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no blots containing extracts of human keratinocytes. 
In IEM studies of pre- and post-en"Ibedded skin, the 
distal ectodomain of BPAG2 localized beneath HDs 
in basal keratinocytes; there was no evidence of 
BP AG2 beneath melanocytes. Anti-BV 4 IgG exten-
sively bound anchoring filaments on the epidermal 
side of 1 M NaCI split skin; this staining extended 
along anchoring filaments to their ends. In post-
embedded skin, the carboxyl terminus ofBPAG2 was 
localized within the lamina densa, 41 nm (mean of 
400 determinations) beneath plasma membranes of 
basal keratinocytes. BPAG2 thus extends from the 
intracellular HD plaque of basal keratinocytes to the 
lamina densa of human epidermal BM. Key 1110rds: 
hemidesmosomeslcollageu/lamiuiu 5. J Itt vest Derma to/ 109: 
200-206, 1997 
BPAG2 is a 180-kDa type II transmembrane protein (i.e., its 
carboxyl terminus is extracellu lar) associated with HDs in basal 
keratinocytes (Diaz ct al, 1990; Li ct a/, 1991; Giudice ct a/, 1992 ; Li 
et al, 1993). The extraceiJuJar domain of BPAG2 consists of 15 
interrupted collagenous segments, and hence this protein has also 
been designated as type XVU coiJagen. The type li orientation of 
this protein as well as the Gly-X-Y collagenous repeats within its 
extracellular domain are similar to the structure of macrophage 
scavenger proteins and the recently identified MARCO (a novel 
macrophage receptor with a coll ageno us structure) prote in-all 
molecules thought to exist in a tri.meric configuration within their 
extracellular domains (Gordon el a/, 1988; Kodama el a/, 1990; 
Rohrer el a/ , 1990; Krieger and Hertz, 1994) . Support for the idea 
that BPAG2 plays an important role in basal keratinocyte adhesion 
to epidermal basement membrane (BM) derives from studies of 
patients with bullous, gestational, and cicatt·i cial pe mphigoid who 
have lgG anti-BPAG2 autoantibodies and subepidermal bliste rs that 
develop within the plan e of the Ia nun a Iu cida (Morrison eta/, 1988; 
Diaz et a/ , 1990; Bernard ct a/, 1992; Liu el a/ , 1993; Balding ct a/, 
1996). Moreover, mutations in COL17 A 1, the gene encoding 
BPAG2, have recently been identified in patients with generalized 
atrophic benign epidermolysis bullosa, an inherite d disease charac-
terized by defective adhes ion of epidermis to epidermal BM 
(McGrath el a/, 1995, l996a, 1996b; Darling el a/, 1997) . 
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Recently, we have expressed recombinant forms of human 
BPAG2 in the eukaryotic baculovirus ex-pression system, a m ethod 
that yields proteins with many of the same post-translational 
modifications that occur in mammalian cells. One of these recom-
binants, BV4, is a 70-kDa polypeptide that corresponds to the distal 
extracellular domain and carbox'Yl terminus of this adhesion mol-
ecule. BV 4 has bee n affinity-purified, characterized, and used to 
raise high-titer and specific polyclonal rabbit IgG. Because the 
precise locaUza tion of the distal extracellular domain and carboxyl 
terminus ofBPAG2 in human epidermal BM is unknown, purified 
anti-BV4 IgG has b een used to localize this protein in pre- and 
post-embedded normal human skin by i.mmunogold electron mi-
croscopy (IEM). In addition, the localization of these most distal 
extracellular domains of BPAG2 in normal human skin has been 
compared to that of laminin 5 (a3{33-y2) using purified, high-
titered, and previously characterized polyclonal anti-lamin.in 5 fgG 
that reacts with all subunits of this protein (Lazarova et al, 1996). 
MATERIALS AND METHODS 
Generation and Characterization of BPAG2 cDNAs A series of 
BPAG2 eDNA clones were generated by using the reverse transcription-
polymerase chain reaction (PCR) as follows. Total RNA from subconfluent 
monolaye r cultures of human keratinocytcs (HKs) was purified on CsCl 
cushions, quantitated, and reverse-transcribed by using random hexamers. 
The resulting eDNA was amplified by PCH ... with 5' and 3' primers 
corresponding to various regions of BPAG2 eDNA (GenBank accession 
number M91669; Giudice ct a/, 1992). PCR mixtures used to generate 
BPAG2 cDNAs contained 1 f.Lg ofHKcDNA, 0.2 f.LM 5' and 3' primers, all 
four dideoxynucleotides (each at 1 f.LM), 2.5 units of Taq DNA polymerase, 
and Taq polymerase butfer (Perkin-Elmer, Branenberg, NJ) in a final 
volume of 100 f.Ll. The PCR mixture was heated to 95°C for 105 s, 
subjected to 35 cycles ofPCR (95°C for 15 s, 56°C for l min) , and then held 
at 72°C for 7 min with a thermocycler (Perki11-Elmer Cetus Gene Amp PCR 
System 9600. Norwalk, CT). Multiple different .BPAG2 cDNAs were 
produced, recovered, and analyzed on agarose gels stained with eth.idium 
bromide. In these preparative experiments, 5' primers for BPAG2 amplifi-
cation encoded (in 5' ~ 3' order), the XIJnl restriction site, 24 nucleotides 
corresponding to the FLAG-tag octapeptide sequence (International Bio-
technologies, New Haven, CT), and 18-22 nucleotides corresponding to 
BPAG2 eDNA. Similarly, the 3' primers for BPAG2 amplification encoded 
18-22 nucleotides corresponding to BPAG2 eDNA and the Not( restriction 
endonuclease site. To generate the eDNA construct encoding BV4, a eDNA 
fragment corresponding to BPAG2 nucleotides 2518-3703 (5' primer, 
GCCGTCTAGAAGACTACAAGGACGACGATGACAAGCCAGGCAA-
GATCGTGACTTCG; 3' primer, CCTCCACGCTGATGCTGGAC) and 
another corresponding to nucleotides 3328-4630 (5' primer, GCCGTC-
TAGAAGTCAGCTTGTTCTCGTCCTCC; 3' primer, CGATGCGGCC-
GCCTGGTCCAGGAGCTGTCCTGC) were digested with EcolU (an 
internal restri.ction endonuclease site), gel-puri fied, and subcloned into 
pBluescript II SK + (Stratagene, LaJolla, CA) via a three-way ligation. BV4 
eDNA in this vector was further characterized by restriction analysis and 
then sequenced by the dideoxynucleotide method of Sanger to ensure that 
the BV4 eDNA did not contain any errors (Sambrook et al, 1989). 
Generation of BV4 Baculovirus BV4 eD NA from pBluescript was 
subcloned into the baculovirus transfer vector pAcGP67 (Pharminogen, San 
Diego, CA). T his vector is a polyhedrin-based transfer vector that results in 
occlusion body-negative recombinants; it also encodes a strong signal 
peptide sequence to promote secretion of recombinant protein into culture 
medium. Infectious virus was made with the BaculoGold expression system 
(Phanninogen). The presence ofBV4 eDNA in multiple BV4 baculovirus 
clones was confirmed by PCR; representative clones were plaque-purified 
twice, titered, and stored at -20°C. 
Production of BV4 Protein Sp"'loptern ji-ugiperda 9 (Sf'J) insect cells 
grown in Sf-900 11 SFM medium (GIBCO/BRL, Gaithersburg, MD) were 
infected with BV4 bacuJovirus at a multiplicity of infection of 10. Within 
24-36 h, SflJ cells showed evidence of viral infection by light microscopy. 
Conditioned medium from S£9 cells was recovered 3 d after viral infection; 
made 100 f.Lg phenylmethylsulfonyl fluoride per ml, 1 f.Lg pepstatin per rnl , 
and 0.5 f.Lg leupeptin per ml; centrifuged at 200 X g for 5 min; and stored 
at - 70 or 4°C. For analysis and characterization of recombinant BV4 
protein, conditioned medium from [35S)rnethionine (50 f.LCi per ml; specific 
activ ity - 1100 C i per mmol; New England Nuclear, Boston, MA) biosyn-
thetically radiolabeled S£9 cells was reduced, applied to 8% Tris(hydroxy-
rnethyl)aminomethane (Tris)-glycine-polyacrylamide minigels, and studied 
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by fluorography . Conditioned medium was also studied by immunoprecipi-
tation with monoclonal antibodies directed against FLAG peptide (Intema-
tional Biotechnologies), the extracellular domain of BPAG2 (a reagent 
kindly provided by K. Owaribe, Nagoya University, Japan) or human IgG 1 
(Southern Biotechnology Associates, Binningham, AL) as described previ-
ously (Stanley et nl, 1981; Basset-Seguin et al, 1988). 
Purification ofBV4 Protein M edium from BV4-baculovi.rus-infected 
S£9 cells was dialyzed against Tris-butfered saline, pH 7 .4, ovemight at 4 oc 
and applied to affinity columns bearing anti-FLAG IgG M2 monoclonal 
antibody (International Biotechnologies). After extensive washing with 
Tris-butfered saline, pH 7.4, BV4 protein was eluted with glycine hydro-
chloride, pH 3 .5, and column fractions were immediately brought to neutral 
pH by the addition of 1 M Tris, pH 8 .0 . The e lution profile ofBV 4 protein 
was determined in ir.ru11unoblot studies of column fractions with anti-FLAG 
M2 monoclonal antibody and affiniry-purifted alkaline phosphatase-conju-
gated goat F(ab') 2 anti-mouse IgG (Tago, Burlingame, CA). Peak column 
fractions were pooled, quantitated by OD280, and furd1er analyzed on 8% 
Tris-glycine-polyacrylamide minige ls (Novex, San Diego, CA) stained with 
Coomassie blue. 
lmnntnization of Rabbits Serum from three New Zealand White 
rabbits were tested for evidence of circulating IgG reactive with human 
epidermis or epidermal BM by indirect immunofluorescence (IF) micros-
copy as previously described (Doml.oge-Hultsch et nl, 1992; Lazarova el a/, 
1996). Pre-immune serum was collected from one rabbit with low back-
ground reactivity to human skin and tlus aruma! was immunized subcuta-
neously with purified BV4 protein (40 f.Lg per ml) suspended in Freund's 
complete adjuvant. Tlus rabbit was given four booster injections at 2-wk 
intervals with the same preparation of BV4 protein (40 f.Lg per ml) 
suspended in incomplete Freund's adjuvant. Immune serum was collected, 
characterized, and purified as described below. 
Characterization of Rabbit A.nti-BV 4 IgG 
Judi reel IF Microscopy Serial dilutions of immune (and pre- imnnme) rabbit 
serum were tested for IgG reactive witlun intact a11d 1 M NaCl split human 
skin by indirect IF microscopy. The same serum was also tested for lgG 
reactive with permeabilized S£9 cells infected with BV4 baculovirus (as well 
as permcabilized wunfectcd SflJ cells, as control). 
lllllltlllloblot immune (and pre-immune) rabbit sera were characte rized for 
their lgG reactivity against aU proteins extracted from cultured HKs by 
immunoblotting as described previously (Lazarova el nl, 1996) . ln these 
experiments, HKs were extracted with Tris-buffered saline, pH 7.4, con-
taining 1% sodium dodecyl sulfate, S0/.1 2-mercaptoetl1ru1ol , 2 mM ethyl-
enediamine tetraacetic acid, 2 mM phenylmetluonylsulfonyl fluorid e, 5 mM 
leupeptin, 5 mM. antipa.i.n, 5 mM chymostatin, and 5 mM pepstatin A. HK 
extracts were boiled for 3 min , loaded onto 8% Tris-glycine-polyacrylamide 
minigels (Novex), transferred to an lmmobilon-P membrane (Millipore, 
Bedford, MA) by electrophoresis, ru1d immunoblotted with immune and 
pre-immune rabbit sera. In ru1alogous experiments, immune (and pre-
immune control) rabbit sera were immunoblotted against total protein 
extracts of S£9 cells infected with BV4 baculovirus. Chetniluminescence 
(ECL, Amersham, Little Chalfont, U .K.) was used to develop these 
immunoblots. 
lmlltllllaprecipitntiall Snbconfluent monolayers ofnom1al HKs were biosyn-
thetically radiolabeled for 2 h with e5S)met11ioaine (50 !J.Ci per mJ; .•pecific 
activity - 1100 Ci per mmol; N ew England Nuclear, Boston, MA) in 
methionine-free medium. Radiolabeled H.K extracts were processed as 
described previously and studied by immunoprecipitation using immune 
and pre-imrmme rabbit sera (Stanley et a/, 1981; Basset-Seguin el nl, 1988). 
lmmunoprecipitation samples were studied by polyacrylamide gel electro-
phoresis and fluorography. 
Purification of Rabbit IgG Immune (and nonnal control) rabbit lgG 
were purified by chromatography on Affi-Gel Blue (Bio-Rad Laboratories, 
Hercules, CA). concentrated by ultrafiltration (Centricon 30. Amicon. 
Danvers, MA), and analyzed on Coomassic blue-stained Tris-glycine-
polyacrylamide minigels containing standards of known concentration as 
described previously (Lazarova et nl, 1996). When these studies confirmed 
that the immune and normal lgG preparations were purified to homogene-
ity, final lgG concen trations were determined by OD280 using an extinction 
coefficient (1%, 1 em) of 13.6. 
;Rabbit Anti-Lami.nin 5 IgG The purified rabbit anti-laminin 5 used in 
these studies was developed, characterized, m1d purified as recently de-
scribed (Lazarova et nl, 1.996). This IgG binds the dennal side of 1 M NaCI 
split human skin, immunoblots and immunoprecipitates all laminin 5 
subunits from extracts and conditioned medium of HKs, shows a profile of 
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tissue reactivity that is identical to the known distribution of laminin 5 iu 
uiuo, and does not react with other matrix proteins present in epidermal or 
other epithelial .BMs. Moreover, after passive transfer of tb.is rabbit anti-
laminin 5 IgG to neonatal mice, subepithelial blisters develop in epidermal, 
oral, and nasa l epithelial BMs-a tissue-specific pattem ofi11jury that further 
attests to the specificity of the lgG. 
Pre-Embedding Immunoelectron Microscopy Eight-micrometer 
cryostat sections of 1 M NaCI split normal human skin cryoprotected with 
10% glycero.l/phosphate-bulfered saline at 4°C for l h were incubated with 
purified anti-BV4 lgG, anti-lamini.n 5 lgG, or contro l normal rabbit lgG (all 
diluted 1:1000) at room temperature for 1 h . Skin sections were subse-
quently incubated with 1 nm, 5 nm (Amersham International, Buckingham-
shire, U .K.), or 15 nm (Zymed Laboratories, San Francisco, CA) gold-
labeled anti-rabbit lgG (di luted l :40) at room temperature for 1. h. After the 
specimens were fixed with 2"1<, glu taraldehyde, 1-nm gold particles w ere 
enlarged with a silve r-enhancement kit (Amersham International) at room 
temperature for 8 min . The spec imens were post-fixed with 1% osmium 
tetroxide, dehydrated through a graded ethanol series, and embedded in 
epoxy resi11 by using the inverted capsule method (Shimizu et nl, 1988) . The 
ultrathin sections were cut and observed with a transmission electron 
microscope OEM- 1200EXII , JEOL, Tokyo, Japan). T lus microscope inter-
nally accounts for the final magnification and nonnative scale bar of each 
micrograph. 
Post-Embedding lmmunoclectron Microscopy with Cryofixation 
and Cryosubstitution without Chemical Fixative Post-embedding 
immunoelectron nucroscopy of cryofixed and cryosubstituted skin was 
carried out as described previously (Shimizu d nl, 1989; Shimizu et nl, 1992). 
Briefly, small pieces of fresh normal human skin were cryoprotected with 
15% glycero l/ phosphate-bulfered sa line at 4°C for 30 min and cryofixed by 
plunging them into liquid propane cooled to - 190°C (KF80, R eichert-
Jung, Vienna, Austria). Skin samples were then subjected to cryosubstitu-
tion (CS-auto, R eichert-Jung) with acetone at - 80°C for 120 h and 
subsequently embedded in Lowicryl Kll M (Chemische Weke Lowi , 
Waldkraiburg, Germany) at - 60°C. The specimens w e re polymerized by 
ultraviolet irradiation at - 600C for 72 h and at room temperature for 
another 72 h. Ultratlun sections were incubated overn ight at 4°C with 
purified anti-.BV4 lgG (1 :2000 dilution), anti-lam in in 5 lgG (1 :400 dilu-
tion), or normal rabbit JgG (1 :2000 d ilu tion). After being washed, each 
section was placed on a drop of 1-nm-gold-labeled goat anti-rabbit lgG 
(diluted 1 :40) at room temperature for 2 h and then washed with distilled 
water. One-nanometer gold particles were amplified with a si lver-enhance-
ment kit at room temperature for 6 min. The sections were coun terstained 
with saturated uranyl acetate and lead citrate for 6 and 2 min, respectively. 
Quantitative Analysis of Gold Particle Distribution Since post-
embedding !EM provides antibodies equal access to target antigens irre-
spective of their location, quantitative analysis of the distribution of gold 
particles corresponding to the localization of BPAG2 in human epidermal 
BM was performed on these electron micrographs as described previously 
(Tshiko cl n/, 1993; Shimizu and Nislukawa, 1993; Masunaga et nl, 1996). All 
electron micrographs used for quantitative studies viewed epidermal BM in 
a p lane perpendicular to the plasma membrane of basal keratinocytes. The 
distance from the outer surface of the plasma membrane to the gold particles 
was measured on electron micrographs. More than 400 gold particles 
beneath l-IDs were randomly examined in these quantitative studies. 
RESULTS 
BV4 Protein Is a 70-kDa Baculovirus-Encodcd Recombi-
nant Specifically Immunoreactive with Monoclonal Anti-
bodies Directed against BPAG2 or FLAG Fluorographs of 
Tris-glycine-polyacry lamide minigels loaded with aliguots of radio-
labeled m e dium from BV4 baculovirus infected (but not uninfected 
control) Sfl) cell s demonstrated the presence of a 70-kDa polypep-
tide that corresponded to the pre dicted molecular weight of BV4 
protein. Moreover, monoclonal antibodies directed against the 
extracellular domain ofBPAG2 or FLAG peptide immunoprecipi-
tated 70-kDa polypeptides from the medium of BV 4 baculovirus-
infected (but not un.infected control) Sf) cells (Fig lA). These 
polypeptides co-migrated with each other as well as the dominant 
70-kDa polypeptide ide ntified in fluorograph.ic studies of condi-
tioned m e dium from Sf) cell s (data not shown). As described 
previously, BV4 prote in was affinity-purified from the conditioned 
medium of Sfl) cells, reduced, applied to 8% Tris-glycine minigels, 
and transfer-red to Tmmobilon-P membranes for immunoblot stud-
THE JOURNAL OF IN VESTIGATIVE DERMATOLOGY 
B c 
1 2 3 4 5 6 1 2 3 4 1 
Figure 1. BV4 protein is a 70-kDa baculovirus-encoded recon>bi-
nant that is specifically immunoreactive with monoclonal antibod-
ies directed against BPAG2 or FLAG peptide. (A) Conditioned 
medium from [3 5S]methiorune biosynthetically radiolabeled .BV4-baculovi-
rus-infected (/nu es 1-3) or control uninfected (lnues 4-6) Sf') cel.l s we re 
studied by immunoprecipitation using monoclonal antibodies directed 
against tl1e extracellular domain ofBPAG2 (lnues 1,4), FLAG peptide (lnues 
2,5), or human lgG 1 (lnues 3,6). lmmunoprecipi tatiou samples were ana-
lyzed as described in Materials nud Metliods. BV 4 protein was identified by 
anti-BPAG2 (lnue 1) and anti-FLAG (ln ue 2) antibodies as a 70-kDa band 
(arrow). All control samples (lnues 3-6) in these immunoprecipitation 
studies were negative. (B) Affiruty-p urified 13V4 protein (Innes 1,3) and a 
FLAG-conjugated control protein (I nternationa l Biotechnologies) (ln11es 
2,4) were studied by immunoblotting as described in Mnterinls mrd M etlwds 
using monoclonal antibodies directed against FLAG peptide (lnues "/ ,2) or 
human lgG, (controls) (lnu es 3,4). Affinity-purified BV4 protein was 
identified as an intact solitary 70-k.Da band (arrow) (ln11c 1), and the 
FLAG-conjugated protein was identified as a smaller band (lnue 2). Mono-
clona l anti-human lgGl showed no reactivity to affinity purified B V 4 (ln11 e 
3) or the FLAG-conjugated control protein (ltme 4). (C) Affinity-purified 
and concentrated BV4 protein used for development of anti-BV4 lgG 
migrated as a soli tary 70-kD~r band (arrow) on an 8% Tris-glycine-
polyacrylamidc minigel sta ined with Coomassic blue. 
ies. In these stud ies, anti-FLAG M2 monoclonal antibody identified 
affini ty-purified BV 4 protein as a solitary 70-kDa fusion protein. 
No other proteins in tlus preparation were identified by monoclonal 
antibodies directe d against the FLAG peptide (indicating that 
acid-glycine e lu tion of isolated BV4 prote in did not generate any 
immunoreactive degradation fi·agments) or human l gG 1 (control) 
(Fig 1B). Reduced a liguots of concentrated BV4 protein used for 
rabbit immunizations appeared as a solitary 70-kDa band free of 
contaminants in 8% Tris-glycine-polyacrylamide mirugels stained 
with Coomassie blue (Fig lC). 
Anti-BV 4 IgG Specifically Binds Epidermal BM and BPAG2 
f~tdircct IP !vficroscopy Circulating IgG from immune (but not 
pre-immune or normal) rabbit serum specifically and exclusively 
bound the epiderma l side of 1 M NaCI split skin (Fig 2). After 
purification, rabbit anti.-BV 4 IgG bound split skin in the identica l 
manner with a titer of 10,240, whereas purified normal rabbit IgG 
Figure 2. Anti-BV 4 IgG specifically binds epidermal BM. By indirect 
IF microscopy, lgG in immune serum bound the epidermal side of 1 M 
NaCI split skin (A). In contrast, lgG in pre-immune senrm showed no 
reactivity to this substrate in contr:ol studies (B). 
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Figure 3. Anti-BV4 IgG immunoblots BPAG2 in extracts ofHKs. 
Total protein extracts of cultured HKs were studied by immunoblotting as 
described in /llfnterinls aud Methods usi.ng immune (laue I) or pre-immune 
(ln uc 2) rabbit serum. lgG in immune serum identified a single 180-kDa 
protein in HK extracts (arrow) (/nne 1) that corresponds to DPAG2. JgG in 
pre-inununc serun1 sbowed n o reactivity to any HK proteins in these 
immunoblot studies (!nne 2). 
remained fiee of reactivity. There was no sta ining of microvascular 
BMs in any of these indirect IF microscopy studies. In related 
experiments, IgG in immune (but not pre-immune) serum stained 
the cytoplasm ofpermeabilized BV4-baculovirus-infected (but not 
un.infected , control) S£9 cells (data not shown). 
llllm111wblot St11dies In immunoblot studies of total protein extracts 
from HKs, lgG in immune rabbit serum specifica lly bound a single 
180-kDa protein (Fig 3). Control immunoblot studies of HK 
extracts using pre-immune rabbit serum were negative (Fig 3) . In 
analogous experiments, immune serum bound a 70-kDa protein in 
the conditioned medium of BV 4-bacu.lovirus-infected (but not 
uninfected, control) S£9 cells; pre-immune serum showed no 
reactivity to either infected or uninfected Sf9 cells (data not 
shown). 
lulltlltlloprccipitatioll Anti-BV4 (but not pre-immune) serum specif-
ically immunoprecipitated a single 180-kDa protein from extracts 
of biosynthetica lly radio labeled normal HKs (Darling ct a/, 1997) . 
Pre-Embedding IEM Studies Localized the Distal Extracel-
lular Domain ofBPAG2 to the Ends of Anchoring Filaments 
IEM studies of pre- embedded 1 M NaCI split skin demonstrated 
that gold particles loca ljzing anti-BV4 lgG were confined excl u-
sively to th e BM on the epidermal side of the test subst1·ate. More 
specifically, the labeling was densely loca lized beneath HDs near 
the ends of anchoring filaments 50-60 nm below plasma m em-
branes of basal keratinocytes (Fig 4A,B). Studies employing sec-
ondary antibodies conjugated to gold particles of different sizes 
(specifically, 1 nm with silver enhancement, 5 JU11, or 15 nm) gave 
the sam e results . No specific labeLing was observed iJ1 other parts of 
this substrate, including the superior surface of the lamina densa. 
In con trast to the ultrastructural localization of the carbo;-.:yl 
terminus of BPAG2, gold particles localizing anti-laminin 5 IgG 
were confin ed exclusively to the dermal side of 1 M NaCl split 
normal human skin. Tlus labeling w as largely confined to the 
superior surf.1ce of the lamina densa near its interface with the 
lamina Iucida (Fig 4C). Anti-lamin.in 5 IgG did not specifically label 
any other part of this substrate includi.ng sites beneath HDs or 
below the lamina densa. The same results were obtained when 
tissue sections were stained with secondary antibodies conjugated 
to either 5- or 15-nm gold particles. Purifted normal rabbit lgG 
showed no specific reactivity to epidermal BM in immunogold EM 
studies of pre-embedded normal human skin . 
Post-Embedding IEM Studies Localized the Carboxyl Ter-
minus ofBPAG2 to the Lamina Densa EM studies confirmed 
that the morphology and ultrastructural detail of tonofilaments, 
HDs, and plasma membranes in basal keratinocytes and of the 
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Figure 4. Pre-embedding IEM of 1 M NaCl split skin localized 
anti-BV4 IgG to the distal ends of anchoring filaments (A,B) and 
anti-latninin 5 IgG to the superior aspect of the lamina dens a (C). 
Secondary antibodies conjugated to 5-nm (A) or 15-nm (B) gold particles 
showed that ant.i-DV4 lgG was densely loca lized beneath hemidesmosomes 
ncar the ends of anchoring filaments ; no specific labeling was observed in 
other parts of the substrate. In parallel studies, gold particles (l nm with 
silver enhancement) loca.lized anti-laminin 5 lgG to the superior aspect of 
the lamina dcnsa (C) : no specific labeling was observed elsewhere in this 
substrate. Scale hnrs, 0.1 [..tm. 
lamina Iu cida, lamina densa, and anchoring fibrils in epiderma l BM 
were satisfactorily preset·ved and int<lct in cryofixed and cryosub-
stituted nonnaJ human skin specimens. Gold particles local.izing 
anti-BV4 IgG in post-embedded human skin (i.e., a substrate w here 
antibodies have equal access to target antigens) found labeling 
within th e superior aspect of the lamin a densa (Fig SA, C) . In these 
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Figure 5. Post-embedding IEM using 
cryofixed and cryosubstituted intact 
normal huntan skin localized anti-BV4 
(A,C) and anti-laminin 5 (B,D) IgG 
within the superior aspect of the lam-
ina densa. One-nanometer gold particles 
were si lver-enhanced at roo m temperature 
for 10 (A,B) o r 6 (C,D) min. Gold particles 
staining anti-BV4 lgG loca lized within the 
superior aspect of the lamina densa; there 
was no staining beneath me lanocytes. Gold 
particles loca lizing anti-laminin 5 IgG also 
showed labeling beneath basal kcratinocytes 
along the superior aspect of the lam i11 a 
densa. Scale bars, 0.2 p.m. 
studies, the majority of gold particles were distributed b eneath HDs 
in basal keratinocytes. As shown in Fig SA , anti-BV4 lgG did not 
bind any portion of epidermal BM beneath melanocytes . 
Gold particles localizing anti -laminin 5 lgG in post-embedded 
hum an skin showed a pattem oflabeling very much like that of the 
carboxyl terminus ofBPAG2 (i.e., labeling beneath basal keratino-
cytes along the superior aspect of the lamina densa) (Fig SB,D). 
Purifted normal rabbit LgG showed no speciftc reactivity to epider-
m al BM in IEM studies of post-embedded normal human skin. 
Quantitative IEM Studies of Post-Embedded Normal Hu-
man Skin Localize the Carboxyl Terminus ofBPAG2 to the 
Lamina Densa A histogram depicting the distribution of goJd 
particles corresponding to the localization of anti-BV4 lgG in 
epidermal BM of post-embedded human skin is shown in Fig 6. 
These studies found that the mean distance fi·om the plasma 
membranes of basal keratinocytes to the carboxyl terminus of 
BPAG2 was 41 mn. This places the carbOJ.]'l terminus of BPAG2 
within the bounds of the lamina densa itself (the margins of the 
la tter having recently been locali zed between 38 and 96 nm below 
plasma membranes of basal keratinocytes; Masunaga et nl, 1996) . 
DISCUSSION 
These IEM studies of pre- and post-embedded normal human skin 
show that the distal extracellular domain of BPAG2 localizes to 
anchorin g filaments and that its carboxyl terminus extends to the 
lamina densa, approximately 40 nm below the plasma membranes 
of basal keratinocytes . Most gold particl es corresponding to these 
distal extra cellul ar domains of BPAG2 localized b eneath HDs. 
Some particles were also noted at other sites beneath basal kerati-
nocytes and may sign ifY the presence of a plasma m embrane 
assoc iated form ofBPAG2 in these cells . BPAG2 w as not detected 
beneath meianocytes, a finding that serves as an additional intemal 
control for these ultrastructural studies. Localization of the car-
boxyl te rminus of BPAG2 within the lamina densa indicates that 
ligand(s) for this adhesion molecule may reside at tlus site as w ell as 
within the lamina Iucida as previously considered . More over, these 
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studies demonstrate that BPAG2 extends from the cytoplasm of 
basal kerati.nocytes to th e lamina densa of epidermal BM . This is the 
first adhesion molecule shown to possess this novel distribution in 
human epidermal BM-a loca lization that implies an im portant and 
uniqu e role for BPAG2 in epidermal adhesion. 
Recent studies of an immunoreactive form of BPAG2 purifi ed , 
not fi·om HDs, but rather from plasma membranes of the 
BMGE+ H bovin e m ammary g land epithelia l ce ll lin e have pro-
vided important insights abou t the possible molecular configuration 
of tlus mol ecule (Hirako et a/, 1996). Sedimentation and chemical 
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F igure 6. Quantitative analysis of the distribution of gold particles 
corresponding to the localization of the distal extracellular domain 
of BPAG2 in post-embedded human epidermal BM. The mean 
distance from the plasma membrane (PM) of basa l keratinocytes to the dista l 
extracellular domain of BPAG2 was 41 nm . T hese studies found that. 
BPAG2 traverses the lamim1 Iucida (LL) and that its ca rboxyl terminus 
extends to the lamina den sa (LD) of human epiderma l BM . 
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cross-linking experiments indicated that this solubl e form of plas-
ma-membrane- associated BPAG2 exists as a trimer. Moreove r, 
rotary shadowing studies suggested that this form of BPAG2 
appears as a quaver- like molecule consistin g of a glo bular head, 
centra l rod do main, and flexib le tail. The shape and dimensions of 
tlus representational model have lead to the sugges tion that BPAG2 
may be a major component of anchoring filaments and that its rod 
domain may be of sufficient length to traverse the lamjna Iu cida 
(Hirako ct a/, 1996). O LII· !E M studies of pre- and post-embedded 
normal human skjn verify this hypothesis, demonstrate that the 
distal extracellular dom ain of BPAG2 locali zes within anchorin g 
filaments , and show that the carboxyl terminus of tlus prote in 
resides within the superior aspect of the lamjJ1a densa. 
In addition to locali z iJ1g the extracellul ar and carbo:-.:yl terminus 
ofBPAG2, our studies suggest that larninin 5 in human epidermal 
BM is primarily found witlun the superior aspect of the lamina 
densa at its interface with the lamina Iucida. Several other studies 
have observed a simil ar pattern of localization. Specificall y, Masu-
naga et a/ (1 996) , using cryo ultramicrotomy, post-embedding !EM, 
and affinity-purifi ed polyclonal antibodies directed against the a3 or 
y2 subunits oflaminin 5, found that this laminin isoform is loca lized 
to the la mina den sa and the interface of the la tter w ith the lamina 
Iucida . Similarly, indirect !EM studies of cryofixed , freeze-substi-
tuted, and post-embedded human skin found that lgG from cica-
tricia l pemphigo id patients with a3-subunit-specific anti-laminin 5 
autoantibod ies bound this same site in human epidermal BM 
(Shjmjzu eta/, 1995). Verrando eta/ (1993) showed that monoclo-
na.l antibody GB3 and polyclonal antibodies directed against each 
laminin 5 subunit bound the lower lamina Iu cida at its boundary 
with the lamina den sa. Fina ll y, recent studies in a passive-o·ansfer 
animal model of cicatricia l pemphigoid demonstrated that purif-ied 
lgG directed against all subun its oflaminiJ1 5 loca lized to the lamina 
densa and the lamina lu cida-lamina dcnsa interfa ce of epidermal 
BM after its administration to neonatal mice (Lazarova eta/, 1996). 
It is entirely possible that laminin 5 resides at other sites within 
epiderm al BM . Tn fact, one prior study using a monoclonal antibody 
against the a subunit of laminin 5 (Ro usselle ct a/, 1991) localized 
this protein to anchoring filam en ts just below the basa l dense plate 
of HDs and along the supel"ior aspect of th e lam ina densa as shown 
herein and elsewhere. What accounts for the partial (and poten-
tially subtle) di sparity between these stud ies is unknown. Findings 
in these ultrastruc tural studies, however, arc generally consistent 
with proposed models of interaction s between laminin 5 and other 
macromo lecu les in epidermal BM. Beca use the short am1s of 
processed lamini n 5 la ck domain s necessary for self polymerization 
and because its truncated y2 subun it does not bind nidogen, laminin 
5 alone is thought to be unabl e to generate stable bindiJ1g of 
epithelial ce ll s to stroma (Mayer cl a/ , 1995). To aclueve such 
stabi li ty, lami.nin 5 is thought to associate with other laminin 
isoforms such as laminins 6 (a3 /31)'1) and 7 (a.3/32)' 1) o r potentially 
even type Vll collagen monom ers themselves (Champliaud et a/ , 
1996) . This compl ex of interactin g prote ins co uld very well exist 
witlun the lamina densa of epidermal BM. Moreover, as has been 
previously suggested, the actual morphology of epidermal BM may 
con sist of a more compacted unit that lacks a lamina Iu cida as 
visualized in conventional EM studies (Goldbe rg and Escaig-1-laye, 
1986; Rousse ll e el a/ , 1991; C han cl a/, l993) . For example, when 
the ultrastructure of epidermal BM is evaluated tmder specia lized 
and high-pressure preservatio n techniques, basa l keratinocytes arc 
more intimately juxtaposed to the lamina dcnsa and anchoring 
fil aments a1·e thought to be telescoped into the latte r to form 
associations with other proteins in this mao·ix. Interestingly, this 
alte rnate mode l more directly proximatcs laminu1 5 with integrins 
ac,/34 and a 3 {3 1 on basal keratinocytes and thus accounts for 
ligand-receptor interactions that arc tho ug ht to play an important 
role in epiderm al adhesion and homeostasis (Carter et a/ , 1991; 
Niessen et a/ , 1994 ; Rousselle and Aumailley, 1994) . Additional 
molecular and ultrastructural studies of proteins in epidermal BM 
will Likely resolve these important issues. 
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